On-site biological specimen collection and reverse transcriptase PCR testing for sars-COV-2 virus
Ended Definitive Contract Awarded Last action
- Contract number
- 19AQMM20C0186
- Awardee
-
Clinical Diagnostic Laboratories, LLC UEI X582GJQGNYN7
- Awarding agency
-
Office of Acquisition Management
Department of State
- Obligated
- $3,527,550
Award facts
- Opportunity
-
- Polymerase Chain Reaction (PCR) COVID-19 Testing Support Pre-Solicitation · 19AQMM20R0309 · Posted Aug 5, 2020
- CDL Enhanced Lab Services Limited / Sole Source Justification · Posted Oct 30, 2020
- Polymerase Chain Reaction (PCR) COVID-19 Testing Support Pre-Solicitation · Posted Aug 20, 2020
- Contract value 100% obligated
- $3,527,550.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Bureau of Medical Services Department of State
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20037, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,145,250 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Novation Agreement | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,672,800 |
Show all 13
About this award
Clinical Diagnostic Laboratories, LLC, doing business as Clinical Diagnostic Lab, was awarded a $3.5 million firm-fixed-price definitive contract by the Department of State Bureau of Medical Services to provide on-site biological specimen collection and reverse transcriptase polymerase chain reaction testing for SARS-CoV-2. The one-year base period contract, with four one-year options, will support testing of approximately 180 personnel annually in the Washington, D.C. area through March 2022. This 100% small business set-aside award fulfills the Department's request for polymerase chain reaction COVID-19 testing support services under a best value tradeoff competition. Clinical Diagnostic Lab will deliver on-site and off-premises specimen collection and processing to detect the presence of the virus causing COVID-19, as initially outlined in the Department's August 2020 solicitation seeking these critical public health services.
Quick answers
Who was awarded contract 19AQMM20C0186?
19AQMM20C0186 was awarded to Clinical Diagnostic Laboratories, LLC by Office of Acquisition Management (Department of State) on September 23, 2020.
How much is contract 19AQMM20C0186 worth?
The government has obligated $3,527,550 on 19AQMM20C0186.
Which agency awarded contract 19AQMM20C0186?
Office of Acquisition Management (Department of State) awarded 19AQMM20C0186, with funding from Bureau of Medical Services (Department of State).
Was contract 19AQMM20C0186 competed?
The extent of competition for 19AQMM20C0186 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award